Renal Cancers Withdrawn Phase 2 Trials for Palifermin (DB00039)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00728585Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell TransplantSupportive Care